ICAM-1 MIMICS AS LFA-1 INHIBITORS
ICAM-1 模拟 LFA-1 抑制剂
基本信息
- 批准号:7960242
- 负责人:
- 金额:$ 9.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-05-01 至 2010-02-28
- 项目状态:已结题
- 来源:
- 关键词:AdhesivesAffinityBiologicalBiomedical ResearchBlood VesselsCell AdhesionCollaborationsComputer Retrieval of Information on Scientific Projects DatabaseDataFlow CytometryFluorescenceFundingGrantHemostatic functionHost DefenseInflammationInstitutionIntegrin alpha4beta1IntegrinsIntercellular adhesion molecule 1InvestigationLabelLaboratoriesLeukocytesLigandsManuscriptsMentorsMolecular ConformationNeoplasm MetastasisNew MexicoPathway interactionsPhysiologicalPlayPreparationResearchResearch PersonnelResourcesRoleSignal TransductionSourceUnited States National Institutes of HealthVascular Cell Adhesion Molecule-1analogdesigninhibitor/antagonistinsightinterestsmall molecule
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Background and Specific Aims
Leukocyte integrins play key roles in vascular cell adhesion in host defense, inflammation, hemostasis, and metastasis. Our new data suggest that the affinity of VLA-4 for VCAM-1 can be regulated under special signaling circumstances by distinct physiological pathways. We hypothesize that there is a specific interplay between conformation, applied force, intracellular signaling, and adhesive function. Therefore, small molecule ligands with ability of manipulating the conformational change can be used for elucidating VLA-4 functions.
We propose to pursue the following specific aims:
1) Design and synthesize known VLA-4 inhibitors, which inhibition modes are not clear;
2) Study their biolgical functions in regulating the VLA-4 and related integrins;
3) Design and synthesize new VLA-4 inhibitors.
Results
We have synthesized 3 known potent and selective VLA-4 inhibitors and their fluorescence-labeled analogues. Despite the fact that these compounds have been shown potent and selective inhibitory effect on VLA-4, their inhibition and activation mode are not known. Therefore, the use of these compounds as probes to study the VLA-4 functions, and conformational changes associated with other integrins such as LFA-1 and ICAM-1 is of considerable biological and medicinal significance. With close collaboration with my mentor Sklar and his group, we have conducted studies of VLA-4 and other integrins. Very interesting and important discoveries have been identified (one manuscript in preparation). More detail mechanistic investigations using fluorescent flow cytometry is under way in our laboratories. The mechanistic insights will help us to design more portent and selective VLA-4 inhibitors.
这个子项目是许多研究子项目中的一个
由NIH/NCRR资助的中心赠款提供的资源。子项目和
研究者(PI)可能从另一个NIH来源获得了主要资金,
因此可以在其他CRISP条目中表示。所列机构为
研究中心,而研究中心不一定是研究者所在的机构。
背景和具体目标
白细胞整合素在宿主防御、炎症、止血和转移中的血管细胞粘附中起关键作用。我们的新数据表明,VLA-4对VCAM-1的亲和力可以在特殊的信号环境下通过不同的生理途径进行调节。我们假设构象、作用力、细胞内信号传导和粘附功能之间存在特定的相互作用。 因此,具有操纵构象变化能力的小分子配体可用于阐明VLA-4的功能。
我们建议实现以下具体目标:
1)设计合成已知的VLA-4抑制剂,其抑制模式尚不清楚;
2)研究它们在调节VLA-4及相关整合素中的生物学功能;
3)设计和合成新的VLA-4抑制剂。
结果
我们已经合成了3个已知的有效的和选择性的VLA-4抑制剂及其荧光标记的类似物。 尽管这些化合物已显示出对VLA-4的有效和选择性抑制作用,但它们的抑制和激活模式尚不清楚。 因此,使用这些化合物作为探针来研究VLA-4的功能以及与其他整合素如LFA-1和ICAM-1相关的构象变化具有相当大的生物学和医学意义。 通过与我的导师Sklar及其团队的密切合作,我们进行了VLA-4和其他整合素的研究。 已经确定了非常有趣和重要的发现(一份手稿正在编写中)。 我们的实验室正在使用荧光流式细胞术进行更详细的机制研究。 这些机理的认识将有助于我们设计出更有前景和选择性的VLA-4抑制剂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WEI WANG其他文献
Pricing and hedging catastrophe equity put options under a Markov-modulated jump diffusion model
马尔可夫调制跳跃扩散模型下的巨灾股票看跌期权的定价和对冲
- DOI:
10.3934/jimo.2015.11.493 - 发表时间:
2014-09 - 期刊:
- 影响因子:1.3
- 作者:
WEI WANG;LINYI QIAN;XIAONAN SU - 通讯作者:
XIAONAN SU
WEI WANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WEI WANG', 18)}}的其他基金
Design of Fe2+ and H2O2 Induced Proximity Functionalized Imaging Probes for the Control of Cellular Functions
用于控制细胞功能的 Fe2 和 H2O2 诱导接近功能化成像探针的设计
- 批准号:
9918434 - 财政年份:2019
- 资助金额:
$ 9.65万 - 项目类别:
Design of Fe2+ and H2O2 Induced Proximity Functionalized Imaging Probes for the Control of Cellular Functions
用于控制细胞功能的 Fe2 和 H2O2 诱导接近功能化成像探针的设计
- 批准号:
10388365 - 财政年份:2019
- 资助金额:
$ 9.65万 - 项目类别:
Organocatalytic Practical Synthesis of Deuterated Building Blocks and Biologically Important Structures
氘代结构单元和生物学重要结构的有机催化实际合成
- 批准号:
9892834 - 财政年份:2018
- 资助金额:
$ 9.65万 - 项目类别:
Organocatalytic Practical Synthesis of Deuterated Building Blocks and Biologically Important Structures
氘代结构单元和生物学重要结构的有机催化实际合成
- 批准号:
9918424 - 财政年份:2018
- 资助金额:
$ 9.65万 - 项目类别:
Organocatalytic Practical Synthesis of Deuterated Building Blocks and Biologically Important Structures
氘代结构单元和生物学重要结构的有机催化实际合成
- 批准号:
10115754 - 财政年份:2018
- 资助金额:
$ 9.65万 - 项目类别:
A SYSTEMATIC APPROACH TO RECONSTRUCTING TRANSCRIPTION NETWORKS IN THE CELL
重建细胞转录网络的系统方法
- 批准号:
7180239 - 财政年份:2005
- 资助金额:
$ 9.65万 - 项目类别:
Enhanced cardiac sympathetic afferent reflex in CHF
CHF 患者心脏交感神经传入反射增强
- 批准号:
6815913 - 财政年份:2004
- 资助金额:
$ 9.65万 - 项目类别:
A SYSTEMATIC APPROACH TO RECONSTRUCTING TRANSCRIPTION
重建转录的系统方法
- 批准号:
6976119 - 财政年份:2004
- 资助金额:
$ 9.65万 - 项目类别:
相似海外基金
Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
- 批准号:
23H01982 - 财政年份:2023
- 资助金额:
$ 9.65万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
- 批准号:
23KJ0116 - 财政年份:2023
- 资助金额:
$ 9.65万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
- 批准号:
10682794 - 财政年份:2023
- 资助金额:
$ 9.65万 - 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
- 批准号:
10598276 - 财政年份:2023
- 资助金额:
$ 9.65万 - 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233343 - 财政年份:2023
- 资助金额:
$ 9.65万 - 项目类别:
Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233342 - 财政年份:2023
- 资助金额:
$ 9.65万 - 项目类别:
Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
- 批准号:
479363 - 财政年份:2023
- 资助金额:
$ 9.65万 - 项目类别:
Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
- 批准号:
10681989 - 财政年份:2023
- 资助金额:
$ 9.65万 - 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
- 批准号:
2237240 - 财政年份:2023
- 资助金额:
$ 9.65万 - 项目类别:
Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
- 批准号:
2305592 - 财政年份:2023
- 资助金额:
$ 9.65万 - 项目类别:
Continuing Grant














{{item.name}}会员




